Related Experiment Video
Updated: Dec 9, 2025

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Cardiac Surgery: Meta-Analysis and Systematic
Azka Latif1, Noman Lateef1, Muhammad Junaid Ahsan1
1Department of Internal Medicine, Creighton University, Omaha, NE 68124, USA.
Insights
Transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) are options for severe aortic stenosis patients with prior surgery. TAVR showed fewer strokes and bleeding, with shorter hospital stays.
Area of Science:
- Cardiology
- Cardiac Surgery
- Interventional Cardiology
Background:
- Increasing number of patients with severe aortic stenosis (AS) have undergone prior cardiac surgery.
- Prior cardiac surgery is associated with increased risks for adverse outcomes during aortic valve replacement.
Purpose of the Study:
- To compare clinical outcomes of transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in patients with severe AS and prior cardiac surgery.
- Evaluate the impact of prior cardiac surgery on key clinical endpoints.
Main Methods:
- Systematic literature search of PubMed, Embase, Google Scholar, and Scopus.
- Included studies compared TAVR and SAVR in patients with prior cardiac surgery.
- Analyzed endpoints: mortality, acute kidney injury (AKI), bleeding, stroke, procedure time, and hospital stay.
Main Results:
- Seven studies with 8221 patients were analyzed.
- TAVR demonstrated a lower incidence of stroke and bleeding complications compared to SAVR.
- No significant differences were observed in AKI or all-cause mortality (30-day and 1-2-year) between TAVR and SAVR.
- TAVR was associated with significantly shorter procedure times and hospital stays.
Conclusions:
- Both TAVR and SAVR are viable options for patients with severe AS and prior coronary artery bypass graft surgery.
- TAVR may offer advantages including reduced stroke and bleeding complications, alongside shorter hospitalizations.
Abstract:
The number of patients with severe aortic stenosis (AS) and a history of prior cardiac surgery has increased. Prior cardiac surgery increases the risk of adverse outcomes in patients undergoing aortic valve replacement. To evaluate the impact of prior cardiac surgery on clinical endpoints in patients undergoing transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR), we performed a literature search using PubMed, Embase, Google Scholar, and Scopus databases. The clinical endpoints included in our study were 30-day mortality, 1-2-year mortality, acute kidney injury (AKI), bleeding, stroke, procedural time, and duration of hospital stay. Seven studies, which included a total of 8221 patients, were selected. Our study found that TAVR was associated with a lower incidence of stroke and bleeding complications. There was no significant difference in terms of AKI, 30-day all-cause mortality, and 1-2-year all-cause mortality between the two groups. The average procedure time and duration of hospital stay were 170 min less (p ≤ 0.01) and 3.6 days shorter (p < 0.01) in patients with TAVR, respectively. In patients with prior coronary artery bypass graft and severe AS, both TAVR and SAVR are reasonable options. However, TAVR may be associated with a lower incidence of complications like stroke and perioperative bleeding, in addition to a shorter length of stay.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management

